Increasing evidence has shown that glycemic instability might contribute to the development of diabetes complications, in addition to the strong relationship between elevated glycemia and diabetes complications risk. In a recent issue of Diabetes Care, an analysis of The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study by Penno et al. 1 has added to the evidence that variability in glycated hemoglobin (HbA 1c ) affects albuminuria and albuminuric chronic kidney disease (CKD) phenotypes independently of, or instead of, average HbA 1c . On the contrary, diabetic retinopathy mainly depends on the average HbA 1c , not variability Glucose variability refers to multiple fluctuations of glycemia in the same individual within-day or day-to-day, or even over longer periods of time; that is, weekto-week or visit-to-visit. The concept of glucose variability was first introduced in the Diabetes Control and Complications Trial (DCCT), and defined as the standard deviation (SD) of daily blood glucose around the mean from each quarterly visit, even though it proved a weak relationship between glucose variability and diabetes complications 2 . In comparison with the inconsistent association between pre-or postprandial glucose variability and microvascular complication risk, HbA 1c variability from visit-tovisit was found to be an independent risk factor for the development of diabetes complications in type 1 diabetes, either solely or in addition to the effect of average HbA 1c .
In the current RIACE study, Penno et al. In contrast to nephropathy, the association between retinopathy and HbA 1c variability was less consistent. Penno et al.
1 speculated that the magnitude of HbA 1c variability was not high enough to affect the development of diabetic retinopathy, and was masked by average HbA 1c and other possible variables related to glycemic exposure, such as diabetes duration and treatments 1 . One fact we cannot deny is that type 1 diabetes might have more variable glycemia than type 2 diabetes does. Furthermore, the RIACE cohort with type 2 diabetes showed that increasing average HbA 1c was associated with longer diabetes duration, whereas higher HbA 1c SD was linked to shorter diabetes duration. In 
